Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,548.00
Ask: 12,550.00
Change: 6.00 (0.05%)
Spread: 2.00 (0.016%)
Open: 12,570.00
High: 12,704.00
Low: 12,472.00
Prev. Close: 12,550.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

In Senegal, lack of cold storage limits COVID vaccine options

Mon, 11th Jan 2021 17:09

By Christophe Van Der Perre

DAKAR, Jan 11 (Reuters) - Senegal does not have the capacity
to store COVID-19 vaccines at ultra-low temperatures and would
prefer to receive vials that can be kept for longer under
ordinary refrigeration, the head of the country's vaccination
programme said on Monday.

A lack of cold storage means Senegal would only be able to
keep vaccines developed by AstraZeneca and Oxford
University, by China or Russia in the long term, as they do not
require a deep freeze, Ousseynou Badiane told Reuters.

Those being distributed by Moderna, which require
storage at minus 20 degrees Celsius (-4 F), and Pfizer
and BioNTech, which need to be kept at -70 degrees
Celsius, are less desirable. Senegal could store the Moderna
vaccine for 30 days and the Pfizer one for seven days but after
that they would be spoiled, Badiane added.

The Moderna and Pfizer vaccines "are not our first choice.
Our first choice is the vaccine that fits easily into the system
that exists, that doesn't require major investment," Badiane
told Reuters.

"If the vaccines are not used (in the right time frame) that
would be an enormous waste."

The situation in Senegal highlights the problems that poorer
countries with hot climates face in storing and distributing
vaccines, often in rural areas with unreliable power supplies.

It also shows how far behind some African countries are in
preparing to receive vaccines even as COVID-19 cases surge to
record levels.

Millions have already received inoculations in Western
countries and China, while Senegal is awaiting vaccines through
the World Health Organization-backed global COVAX scheme. This
programme is helping to finance deliveries to 92 developing
nations with limited or no means to buy vaccines on their own.

Senegal is no stranger to vaccination campaigns.

In four walk-in cold rooms in the capital Dakar, authorities
keep thousands of vials of yellow fever and hepatitis B vaccines
at between 2 and 8 degrees Celsius. It has one room that keeps
oral polio vaccines up to minus 25 degrees Celsius.

At the Fann hospital in Dakar, technicians are installing
seven new such rooms. But for now the lack of deep refrigeration
limits the country's options.

"If the option now is to take the (Pfizer or Moderna)
vaccines we... would have to redo all our logistics," Badiane
said.
(Writing by Edward McAllister;
Editing by Hereward Holland and Gareth Jones)

More News
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.